M. H. Frick

11.0k total citations · 3 hit papers
106 papers, 8.6k citations indexed

About

M. H. Frick is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. H. Frick has authored 106 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. H. Frick's work include Cardiac Imaging and Diagnostics (25 papers), Lipoproteins and Cardiovascular Health (16 papers) and Cardiac electrophysiology and arrhythmias (11 papers). M. H. Frick is often cited by papers focused on Cardiac Imaging and Diagnostics (25 papers), Lipoproteins and Cardiovascular Health (16 papers) and Cardiac electrophysiology and arrhythmias (11 papers). M. H. Frick collaborates with scholars based in Finland, Sweden and Norway. M. H. Frick's co-authors include Vesa Manninen, Matti Mänttäri, Jussi K. Huttunen, Pekka Koskinen, Olli P. Heinonen, Leena Tenkanen, Amos Pasternack, Matti Romo, Esko A. Nikkilä and J Pikkarainen and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. H. Frick

105 papers receiving 7.9k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

1987 2.9k citations M. H. Frick, Olli P. Heinonen et al. profile →
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

1992 1.1k citations Vesa Manninen, Leena Tenkanen et al. Circulation profile →
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

1992 636 citations Pekka Saikku, Maija Leinonen et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. H. Frick Finland	34	4.3k	3.5k	2.5k	1.1k	1.1k	106	8.6k
Vesa Manninen Finland	39	5.0k 1.2×	4.8k 1.4×	2.7k 1.1×	1.4k 1.2×	1.2k 1.1×	144	11.2k
Matti Mänttäri Finland	33	4.1k 1.0×	3.6k 1.0×	2.3k 0.9×	1.1k 1.0×	986 0.9×	59	8.7k
A R Lorimer United Kingdom	29	5.9k 1.4×	3.3k 0.9×	2.8k 1.1×	875 0.8×	1.3k 1.2×	112	9.5k
Amos Pasternack Finland	45	3.3k 0.8×	2.3k 0.7×	1.6k 0.6×	1.5k 1.3×	725 0.7×	252	10.1k
B. Lewis United Kingdom	46	3.2k 0.8×	3.1k 0.9×	1.8k 0.7×	825 0.7×	1.1k 1.0×	149	7.0k
Basil M. Rifkind United States	34	2.7k 0.6×	3.3k 1.0×	1.5k 0.6×	669 0.6×	716 0.7×	109	7.0k
Jiří Fröhlich Canada	51	4.8k 1.1×	3.8k 1.1×	2.3k 0.9×	1.4k 1.2×	1.2k 1.1×	166	10.2k
Russell Scott New Zealand	45	4.8k 1.1×	5.9k 1.7×	1.9k 0.8×	2.7k 2.3×	656 0.6×	235	11.4k
Hanna E. Bloomfield United States	37	4.3k 1.0×	3.9k 1.1×	2.1k 0.8×	1.2k 1.0×	1.1k 1.0×	82	8.1k
Peter O. Kwiterovich United States	54	6.4k 1.5×	4.7k 1.4×	2.3k 0.9×	2.0k 1.8×	1.5k 1.4×	195	11.7k

Countries citing papers authored by M. H. Frick

Since Specialization

Citations

This map shows the geographic impact of M. H. Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. H. Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. H. Frick more than expected).

Fields of papers citing papers by M. H. Frick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. H. Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. H. Frick. The network helps show where M. H. Frick may publish in the future.

Co-authorship network of co-authors of M. H. Frick

This figure shows the co-authorship network connecting the top 25 collaborators of M. H. Frick. A scholar is included among the top collaborators of M. H. Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. H. Frick. M. H. Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pölzl, Gerhard, et al.. (2010). Medikamentöse Therapie der Perikarditis - Bedeutung von Colchicin. Journal für Kardiologie (Krause & Pachernegg GmbH). 18(1). 30–34. 1 indexed citations

Elrayess, Mohamed A., Karen E. Webb, David M. Flavell, et al.. (2003). A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. Atherosclerosis. 168(1). 131–138. 31 indexed citations

Syvänne, Mikko, Marja‐Riitta Taskinen, Markku S. Nieminen, et al.. (1997). A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. Controlled Clinical Trials. 18(1). 93–119. 20 indexed citations

Mänttäri, Matti, Vesa Manninen, Timo Palosuo, et al.. (1994). Serum ferritin and ceruloplasmin as coronary risk factors. European Heart Journal. 15(12). 1599–1603. 110 indexed citations

Hautanen, Aarno, Matti Mänttäri, Vesa Manninen, M. H. Frick, & Herman Adlercreutz. (1992). Effects of gemfibrozil treatment on serum levels of androstanediol glucuronide and adrenal androgens. The Journal of Steroid Biochemistry and Molecular Biology. 42(3-4). 433–434. 6 indexed citations

Saikku, Pekka, Maija Leinonen, Leena Tenkanen, et al.. (1992). Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study. Annals of Internal Medicine. 116(4). 273–278. 636 indexed citations breakdown →

Manninen, Vesa, Leena Tenkanen, Pekka Koskinen, et al.. (1992). Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.. Circulation. 85(1). 37–45. 1093 indexed citations breakdown →

Heliö, Tiina, E H Ludwig, Aarno Palotie, et al.. (1991). Apolipoprotein B gene 3'hypervariable region polymorphism and myocardial infarction in dyslipidemic Finnish men participating in a primary prevention trial. Nutrition Metabolism and Cardiovascular Diseases. 1. 178–182. 5 indexed citations

Virtanen, Kari, et al.. (1991). Coronary Collateral Circulation. Clinical Cardiology. 14(2). 111–118. 13 indexed citations

10.

Mänttäri, Matti, Jussi K. Huttunen, Pekka Koskinen, et al.. (1990). Lipoproteins and coronary heart disease in the Helsinki Heart Study. European Heart Journal. 11(suppl H). 26–31. 33 indexed citations

11.

Frick, M. H., Vesa Manninen, Jussi K. Huttunen, et al.. (1990). HDL-Cholesterol as a Risk Factor in Coronary Heart Disease. Drugs. 40(Supplement 1). 7–12. 31 indexed citations

12.

Manninen, Vesa, et al.. (1989). Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. The American Journal of Cardiology. 63(16). 42–47. 63 indexed citations

13.

Mänttäri, Matti, M. H. Frick, Olli P. Heinonen, et al.. (1987). The Helsinki Heart Study: Basic design and randomization procedure. European Heart Journal. 8(suppl I). 1–29. 44 indexed citations

14.

Virtanen, Kari, et al.. (1986). Studies on ergometer exercise testing I. Significance of the type of st‐segment response, sex, and chest pain. Clinical Cardiology. 9(7). 315–322. 7 indexed citations

15.

Nikkilä, E, et al.. (1984). Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.. BMJ. 289(6439). 220–223. 98 indexed citations

16.

Berg, K., A L Børresen, M. H. Frick, G. Dahlén, & E. R. Trethewie. (1976). SERUM-H.D.L. IN ATHEROSCLEROTIC HEART-DISEASE. The Lancet. 307(7967). 1014–1014. 15 indexed citations

17.

Frick, M. H., et al.. (1976). Analysis of coronary collaterals in ischaemic heart disease by angiography during pacing induced ischaemia.. Heart. 38(2). 186–196. 18 indexed citations

18.

Frick, M. H., et al.. (1970). Cardiovascular dimensions and moderate physical training in young men.. Journal of Applied Physiology. 29(4). 452–455. 21 indexed citations

19.

Frick, M. H., R Balcon, David F. Cross, & E Sowton. (1968). Hemodynamic Effects of Nitroglycerin in Patients with Angina Pectoris Studied by an Atrial Pacing Method. Circulation. 37(2). 160–168. 53 indexed citations

20.

Frick, M. H.. (1960). Influence of 5-Hydroxytryptamine on Renal Function in Extracorporeal Circulation. Nature. 187(4737). 609–610. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact